Galderma (SWX:GALD) has unveiled results from the world’s most extensive skin quality profiling survey, finding that skin quality concerns are widespread, can impact emotional wellbeing and, while ...
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the release of a new clinical study demonstrating the significant prognostic value of its ...
The Damon Runyon Cancer Research Foundation recently awarded two Fred Hutch postdoctoral fellows grants to support ...
Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
Around Scottsdale, Axon Enterprise has been in the news for more than three years – with controversy over its plan to build ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results